ArticleJournal of robotic surgery2026
An international multicenter experience with the Senhance
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Beyond da Vinci: a systematic review of next-generation multiport robotic platforms in pediatric surgery.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our previous studies indicated that the Senhance® Surgical System (SSS®) is safe and feasible for a wide spectrum of abdominal indications in children, with results comparable to conventional laparoscopy. This multicenter cohort study represents the largest published series of pediatric Robotic-Assisted Surgery (RAS) procedures performed with the SSS® to date and complements the existing evidence, which is currently based on single-center studies. A total of 152 pediatric patients underwent a variety of RAS procedures (including upper abdominal-, lower abdominal-, and thoracic procedures) using the SSS® between 2020 and 2025 at two European tertiary referral centers and were consecutively enrolled in the study and analyzed. Of these, 23 children (15%) were younger than 1 year old and/or weighed less than 10 kg at the time of surgery. Conversion from RAS to conventional laparoscopy occurred in 17 cases (11%), with a significantly lower rate observed in lower abdominal procedures, and most often due to suboptimal trocar placement. Only one case was converted to an open procedure, with no conversions in the small children subgroup. Intraoperative- and postoperative complication rates were low, regardless of procedure type or patient age. Mean docking time decreased progressively over the course of the study (p = < 0.001). Utilization of SSS® for RAS is safe and feasible across the entire pediatric spectrum of surgical procedures and patients, including infants younger than one year and children weighing less than ten kilograms. With increasing experience, the SSS® has significant potential to advance minimally invasive surgery in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.